Maker of Botox wrinkle treatment attracts $45.6B bid from activist investor Ackman and Valeant Pharma

Maker of Botox wrinkle treatment attracts $45.6B bid from activist investor Ackman and Valeant Pharma

April 22, 2014 12:26 pm by | 0 Comments

Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle…


Amidst Gilead’s Hepatitis C pill patent debate in India, concerns about access to breakthrough drug

Amidst Gilead’s Hepatitis C pill patent debate in India, concerns about access to breakthrough drug

April 21, 2014 10:42 am by | 0 Comments

A cure for hepatitis C might seem like welcome news in India, where 12 million people suffer from the disease. But the country isn’t quite rolling out the red carpet…



Biopharma company raises $21.5M to treat inflammatory skin disorders

Biopharma company raises $21.5M to treat inflammatory skin disorders

January 2, 2014 12:23 pm by | 0 Comments

A biopharma management company has created a new business that will use liver X receptor agonists to take on dermatological disorders. NeXeption has raised $21.5 million in a Series A…


Drug shortage list climbs to 300+. What are hospitals, politicians, manufacturers doing about it?

Drug shortage list climbs to 300+. What are hospitals, politicians, manufacturers doing about it?

December 22, 2013 8:42 am by | 0 Comments

The prescription drug Dopamine is so valuable to Dayton Children’s Hospital that what is left of its dwindling supply is kept in a vault, accessible only by the medical center’s…


With 5 postponed public offerings this month, is the IPO window beginning to close for biotechs?

With 5 postponed public offerings this month, is the IPO window beginning to close for biotechs?

November 21, 2013 11:36 am by | 0 Comments

A biopharmaceutical company led by former Cephalon CEO Kevin Buchi has pulled its $103.5 million initial public offering shortly before it was due to begin trading this morning. TetraLogic Pharmaceuticals’ …


How will Obamacare impact drug spending? Tough to say

How will Obamacare impact drug spending? Tough to say

November 19, 2013 8:57 am by | 2 Comments

The impact of the Affordable Care Act has been the subject of much discussion in the pharmaceutical industry. The initial enrollment period has been a bit rickety for consumers and…


How Pfizer reclaimed its Twitter handle: a surreal look at corporate social media

How Pfizer reclaimed its Twitter handle: a surreal look at corporate social media

November 16, 2013 7:30 am by | 0 Comments

Proving one’s identity can be a tricky thing on Twitter. There are probably few things more galling than identity theft. And yet, Twitter has been the source of many incidents…



Report: 5 ways pharma could improve the consumer experience

Report: 5 ways pharma could improve the consumer experience

November 13, 2013 10:03 am by | 3 Comments

Update Last year, pharmaceutical companies spent $3 billion in direct-to-consumer promotions. But a healthcare business intelligence report by PwC ‘s Health Research Institute concludes that with such a high investment,…


FDA urges more safeguards for prescription opioid painkiller refills

FDA urges more safeguards for prescription opioid painkiller refills

November 10, 2013 5:35 pm by | 2 Comments

It’s a common scenario. A barely-used bottle of Vicodin, prescribed for your teenage son when his wisdom teeth were extracted, sits in your medicine cabinet for months — until your…


Which venture capital firm’s healthcare investment picks secured the most IPOs?

Which venture capital firm’s healthcare investment picks secured the most IPOs?

October 30, 2013 2:52 pm by | 0 Comments

Biotechnology and healthcare companies have been going public at a good clip this year, at a rate that overshadows the past few years. But initial public offerings are not what…


German company selling version of U.S. drugmaker’s cancer treatment medicine

German company selling version of U.S. drugmaker’s cancer treatment medicine

October 28, 2013 9:02 am by | 0 Comments

FRANKFURT (Reuters) – Germany’s Stada will sell a version of U.S. drugmaker Amgen’s blockbuster cancer treatment filgrastim in Europe, keeping faith with the difficult market for copies of medicines developed…


Biogen Idec’s new multiple sclerosis drug profits impressive $488M

Biogen Idec’s new multiple sclerosis drug profits impressive $488M

October 28, 2013 7:35 am by | 0 Comments

(Reuters) – Biogen Idec on Monday reported $286 million in third-quarter sales of its high-profile new multiple sclerosis drug Tecfidera, providing fresh evidence that the medicine is off to an…


Drug maker seeking prostate cancer drug buyer after weak sales

Drug maker seeking prostate cancer drug buyer after weak sales

October 25, 2013 8:00 pm by | 0 Comments

(Reuters) -


Zogenix’s long-acting drug to treat severe pain approved by FDA

Zogenix’s long-acting drug to treat severe pain approved by FDA

October 25, 2013 2:10 pm by | 0 Comments

(Reuters) – Zogenix Inc said the U.S. Food and Drug Administration approved its drug for treating pain severe enough to require around-the-clock, long-term treatment, sending the specialty pharmaceutical company’s shares…


EU gives clearance for Cimzia drug in psoriatic arthritis

EU gives clearance for Cimzia drug in psoriatic arthritis

October 25, 2013 9:48 am by | 0 Comments

BRUSSELS (Reuters) – Belgian pharmaceutical group UCB said on Friday that European regulators have recommended approval of its Cimzia drug for treating psoriatic arthritis in adults. UCB said that the…